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Summary 
Chondrocyte-collagen composites were evaluated for resurfacing of large articular defects. Isolated chondrocytes were 
cultured in expanded collagen scaffolds for 7-10 days to provide a composite containing 3.6 × 104 cells/mm 3.The graft 
was transplanted into 15 mm full thickness articular defects in the femoropatellar joint of 12 horses using arthroscopic 
techniques. Ungrafted efects in the opposite femoropatellar joint served as controls. Synovial fluid, clinical progress 
and pain responses were evaluated in groups of 6 horses over 4-month and 8-month periods. Following termination, 
gross, histochemical and histologic evaluations of the repair tissues and synovial membrane were performed. 
Arthroscopic defect debridement and chondrocyte implantation resulted in minimal post-operative effusion or pain, 
and synovial fluid constituents were not significantly different in grafted and ungrafted joints. Gross differences in 
grafted defects were not apparent. Increased chondrocyte numbers and cartilage histochemical staining were evident 
in the deeper layers of grafted efects, whereas ungrafted efects were almost entirely fibrous tissue. The surface layers 
of grafted defects were fibrous tissue. There were no synovial f uid cellular responses, ynovial membrane histiocytic 
reaction or subchondral bone infiltrates to suggest immune-related reaction to the allograft cells. Chondrocyte- 
collagen grafts were arthroscopically implanted and resulted in improved cartilage healing in extensive defects. 
However, the structural organization of the surface layers was inadequate and suggested poor long-term durability. 
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Introduction 
NORMAL art icu lar  cart i lage is a highly organized, 
nonhomogenous tissue composed pr imari ly  of 
chondrocytes,  collagen, proteoglycans,  and non- 
col lagenous proteins. The proport ion of cells to 
matr ix  in mature cart i lage is low compared to 
many tissues. The immediate biomechanical  prop- 
ert ies of cart i lage, such as durabi l i ty,  stress dissi- 
pat ion and stiffness, are dependent upon the 
st ructure  and type of col lagen and the proteo- 
glycan confined with in it. This highly ordered 
st ructure  of art icular  cart i lage gives it bio- 
mechanical  propert ies that  unfor tunate ly  have 
not been dupl icated in any current ly  avai lable 
replacement  [1]. 
Superficial defects in art icu lar  cart i lage do not 
heal to any signif icant degree [2-5]. Defects that  
penetrate the zone of calcified cart i lage heal to 
some extent,  but the new tissue is pr imari ly fibrous 
tissue in the surface layers and f ibrocart i lage in 
the deeper zones [6]. The repair  t issue that  does 
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form provides l itt le res istance to oblique compres- 
sive forces [7], and over t ime may also deter iorate  
or dedif ferent iate o fibrous tissue [6]. Resurfac ing 
techniques are required that  will promote not only 
a morphological ly  organized hyal ine surface, but  
one capable of long-term funct ion wi thout  dis- 
integrat ion or cel lular dedifferentiat ion. Further ,  
such techniques need to create minimal donor  site 
morbidi ty and be pract ical ly  applicable to cl inical  
diseases. Signif icant art icu lar  damage results in 
osteoarthr i t is  (OA), which is progressive and a 
major  cause of morbidity. Biological cart i lage 
resurfac ing techniques intercept  he progression of 
focal cart i lage loss to prevent  such irreversible 
OA. 
Surgi~cal graft ing procedures to resurface art icu- 
lar cart i lage defects have not been part icu lar ly  
successful. Per iosteal  grafts resulted in poor  re- 
sults when applied to large defects [8, 9]. Auto- 
genous osteochondral  grafts have shown some 
promise in research models. However,  the donor  
art icu lar  surface is disrupted and degenerat ive 
jo int  disease can develop if the graft is extensive 
[10,11]. Fresh osteochondral  al lografts induce 
excessive immune responses, leading to fa i lure 
[11, 12]. Freezing decreases the immunogenic i ty  of 
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the grafts [13]; however, the chondrocytes are 
severely damaged, which decreases the util ity of 
the graft. Sternal cartilage autografts have shown 
promise in studies in animal models, but long-term 
durability has been less satisfactory, and there is 
still a need for an arthroscopic technique for 
insertion before clinical use can be expected 
[14, 15]. 
Chondrocyte allografts combined with fibrin- 
based vehicles [16], hyaluronic acid [17], or colla- 
gen gels [18] have been used to successfully 
resurface full thickness articular cartilage defects 
in rabbits and chickens. Studies on the isolation 
and cryopreservation f equine chondrocytes have 
allowed the pursuit of resurfacing techniques 
in much larger animal models, using allograft 
chondrocytes implanted in various vehicles [19]. 
Chondrocytes secured in 12-mm defects by a fibrin 
matrix resulted in organized repair tissue contain- 
ing 62% type II collagen [20,21]. The fibrin 
matrix provided 3-dimensional support, prevented 
chondrocyte dedifferentiation toward fibroblasts, 
and protected the cells from the host immune 
response [22]. Although allograft chondrocytes 
are antigenic, the surface antigens can be exten- 
sively masked if the cells are allowed to produce 
their own matrix by incubation prior to implan- 
tation [23, 24]. Fibrin vehicles make incubation 
prior to implantation unnecessary. However, 
fibrin is difficult to attach in the graft site [20]. 
Hyaluronan has also been used as a vehicle to 
implant cultured chondrocytes into small articular 
defects in laboratory animals, with the same 3- 
dimensional benefits as fibrin-based vehicles [17]. 
However, hyaluronate compounds have no ad- 
hesive qualities and little stiffness to assist in 
anchoring the chondrocyte-laden vehicle into 
large defects. 
Purified bovine type I collagen scaffolds have 
been used in vitro to culture murine chondro- 
progenitor cells, and have been embedded with 
chondrocytes and implanted to successfully re- 
surface articular defects in rabbits [25, 26]. The 
collagen scaffolds provide stiffness to the implant, 
allowing it to be pressed securely into the defect. 
Equine chondrocytes embedded in collagen 
scaffolds and cultured in vitro have been shown to 
survive and synthesize cartilage matrix products 
[27]. The development of a collagen vehicle for 
arthroscopic hondrocyte implantation of exten- 
sive full thickness defects in horses would provide 
a suitable and challenging model to confirm and 
expand the positive results of these composites in 
laboratory animals. The objectives of this study 
were to assess the clinical progress, synovial fluid 
response, and the gross and histologic appearance 
of the repair tissue following chondrocyte- 
collagen composite transplantation. 
Mater ia ls  and methods  
CELL CULTURE 
Donor articular cartilage was aseptically 
harvested from the joints of a 3- and a 6-month-old 
foal. During the harvest procedure the cartilage 
was lavaged with Gey's balanced salt solution 
(GBSS; GIBCO-Life Technologies INC., Grand 
Island, NY). The cartilage was kept ~n GBSS on 
ice, weighed, transported to a laminar flow hood 
and then diced into approximately 1-mm squares. 
The cartilage matrix was then digested to release 
the chondrocytes as previously described [19]. 
Briefly, the diced cartilage waS added to filter 
sterilized 0.075% (w/v) collagenase (type CLS 1 
from Clostridium histolyticum, 169U/mg, Wor- 
thington Biochemicals, FreeholdS, NJ) in Ham's 
F-12 medium (GIBCO-Life) supplemented with 
50#g ascorbic acid/ml, 30pg ~-ket0glutaric acid 
(as the monopotassium salt)/ml (GIBCO-Life), 
300 pg of L-glutamine/ml (GIBCO-Life)i. 10% fetal 
bovine serum (GIBCO-Life), 500 units sodium peni- 
cillin/ml (GIBCO-Life) and 500pg streptomycin 
sulfate/ml (GIBCO-Life). Twenty-five mM HEPES 
(GIBCO-Life) was used to buffer the solutions. 
The cartilage and collagenase solution were 
placed in an erlenmeyer flask and stirred on a 
magnetic stirrer for 18 h at 37°C. The cell enzyme 
mixture was then filtered through four layers of 
sterile gauze and one layer of nylon mesh (44 #m) 
to remove the extracellular matrix debris. The 
filtrate containing chondrocytes was then centri- 
fuged at 260g for 10rain. The supernatant was 
discarded and the cell pellet resuspended. An ali- 
quot of cell suspension was removed for a cell 
count and viability determination us ing a dye 
exclusion test (erythrosin B; Sigma Chemical Co., 
St. Louis, MO). The freshly isolated cells were 
resuspended in supplemented Ham's F-12 contain- 
ing 10°//o DMSO, and l ml aliquots containing 
10 × 106 cells/ml were placed in cryotubes and 
frozen at a rate of - 1°C per minute to - 80°C. The 
chondrocytes were then stored at -196°C until 
needed. 
COLLAGEN SCAFFOLD PREPARATION 
The porous collagen matrices were commercially 
available for investigational use and were supplied 
as sterile packages of six 16-mm diameter discs 
(Colla-Tec Inc., Plainsboro, NY). The matrices 
were predominantly composed of type I collagen 
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purified from bovine Achilles' tendon. The material 
was processed to eliminate contact sensitization or 
tissue irritation, and yet maintain its triple helical 
configuration [28]. Left in situ it is progressively 
and completely resorbed from implantation sites. 
Previous light microscopic studies describe the 
open mesh porous network of these collagen 
sponges [27]. 
Six days prior to incorporation of the cells 
into the collagen scaffold, the suspensions were 
thawed, and number and viability determined 
using the erythrosin-B exclusion method. The cells 
were cultured in 25- or 75-cm 2flasks with 10 ml or 
30 ml of supplemented Ham's F-12, respectively. A 
high seeding density of 4 x 10 ~ cells/cm 2 was used 
in the flasks. The cells were incubated in 5~/o CO2 
and 90% humidity for 6 days. Supplemented Ham's 
F-12 media was replaced on day 3, or sooner if the 
media was exhausted. Between the 6th and 9th day, 
the chondrocyte monolayer was trypsinized using 
0.05% trypsin (GIBCO-Life), a cell count was per- 
formed, and 8 × 10 ~ cells were resuspended in 
0.25 ml of supplemented Ham's F-12 and drawn into 
the interstices of a 16-mm diameter collagen 
scaffold using a gentle vacuum. The concentration 
of cells in the scaffold was 3.6 × 104 cells/mm 3.The 
disc shaped chondrocyte composite was then cov- 
ered on both sides by 0.25 ml neutralized, chilled 
(4°C), liquid collagen (vitrogen; Collagen Corpor- 
ation, Palo Alto, CA). Vitrogen is a 99.9% pure 
collagen solution, derived from pepsin-solubilized 
bovine dermal collagen, and dissolved in 0.012 N 
HC1 to establish a 3 mg/ml collagen solution with 
a pH of 2. This product is 95-98% type I collagen 
with the remainder being type III collagen. The 
collagen-coated disc was a l lowedto polymerize in 
a 16-mm 12-well plate in an incubator for 30 min, 
and was then covered with lml  of supplemented 
Ham's F-12. The chondrocyte-laden collagen discs 
(Fig. 1) were incubated for 6-12 days prior to 
implantation in joints, with media change every 
3 days. 
SURGICAL  D ISK  IMPLANTATION 
Twelve normal horses, weighing between 
410-500 kg, and between the ages of 2-8 years, were 
used for this study. Clinical examination verified 
there were no significant joint effusions or hind- 
limb lameness present before the animals were 
included in the trial. 
For the implantation procedure the horses were 
anesthetized, and placed in dorsal recumbency. 
Both femoropatellar joints were prepared for asep- 
tic surgery and the left or right leg was chosen at 
random to be the site for chondrocyte graft. The 
contralateral limb served as the sham control. A 
sample of joint fluid was obtained from each 
femoropatellar joint. The joint was distended with 
saline and an arthroscope inserted into the distal 
aspect of the joint between the middle and lateral 
patellar ligaments as described in standard texts 
[29]. The art icular surfaces were examined to deter- 
mine there were no previous cartilage lesions or 
FIG. 1. A collagen scaffold laden with chondrocytes ( mall arrows). The fibres of the scaffold (large arrows) and the 
coating of near transparent polymerized liquid collagen on the surface (open arrow) can be seen (H & E; × 312). 
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FIG. 2. Arthroscopic approach to the equine lateral 
femoral trochlea. The 16mm cannula for instrument 
access and graft implantation is shown. 
aligned 1-mm diameter holes were drilled 10 mm 
apart to a depth of 20 mm into the subchondral 
bone using a 1.14-mm K-wire. The collagen disc 
containing chondrocytes was then removed from 
the incubator and inserted own the cannula into 
the joint. The disc was gently manipulated into 
position and pressed into the defect to form a 
smooth surface approximately evel with the per- 
imeter cartilage. It was then secured by inserting 
a 1.1mm × 15mm polylactic acid tack (Biofix 
Minitack, Biocon Ltd, Tampere, Finland) into each 
pre-drilled hole. The tacks were driven into the 
bone to hold the disc in place without compressing 
the disc substance. The gas was removed from the 
joint and lactated Ringer's solution :was used to 
irrigate the cartilage and chondrocyte-polymer 
surfaces and interfaces. The residual fluid was 
expressed from the joint and the skin closed with 
nylon sutures. The control hindlimb was examined 
in an identical manner and a cartilage lesion made 
using the same technique. The axSal holes were 
drilled into the subchondral bone as in the exper- 
imental side; however, no chondroc~te-collagen 
disc was placed in the control side defect. The joint 
was flushed and closed as on the experimental side. 
Procaine penicillin (22 000 IU/kg i.m.) was adminis- 
tered 2 h prior to surgery and 6 h post-operatively. 
Phenylbutazone (4.4mg/kg p.o.) and detomidine 
(16 # g/kg i.m.) were given post-operatively as anal- 
gesics. Synovial fluid samples were drawn at the 
time of surgery, and on days 4, 7, 14, 30 and 120 or 
240 following surgery.  
synovial inflammation. An 18-gauge, 8.9-cm spinal 
needle was placed through the skin approximately 
4 cm distal to the apex of the patella and into the 
joint between the middle and lateral patellar liga- 
ments, to locate the central aspect of the lateral 
trochlea of the femur. An 18-20 mm incision was 
made through the skin, subcutaneous tissues, and 
joint capsule at the point indicated by the spinal 
needle. A 16-ram internal diameter cannula was 
placed into the joint, centered on the lateral troch- 
lear ridge of the femur and 2 cm distal to the apex 
of the patella. A modified spade bit 16mm in 
diameter was used to remove a full-thickness layer 
of cartilage and 1 mm of subchondral bone (Figs 2 
& 3). The lactated Ringer's solution used to distend 
the joint was replaced by sterile helium gas and the 
subchondral bed of the cartilage lesion dried by 
inserting several lint-free sponges. Two axially 
FIG. 3. Intraoperative arthroscopic view of a 16mm 
defect in the equine lateral femoral trochlea prior to 
graft implantation. Two holes can be seen (arrows) 
where tacks that anchor the graft were placed. Control 
defects appeared as this photograph depicts. 
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POST-OPERATIVE PROTOCOL 
Four weeks post-operatively, walking exercise 
for 10rain daily was commenced and increased 
each week by 5min daily, over a period of 4 
additional weeks. The horses were then allowed 
out on a half acre pasture until the termination of 
the experiment. The horses were divided randomly 
into two equal groups; one group of horses were 
euthanized at 120 days post-operatively and one 
group at 240 days post-operatively. Immediately 
prior to euthanasia nother lameness exam was 
performed on each horse. The degree of lameness 
was scored using a degree/5-scale system. 
GROSS PATHOLOGICAL EXAMINATION 
The horses were euthanized and the stifle joints 
removed without opening the joint capsule. 
Synovial fluid was aspirated, quantitated, and ana- 
lyzed as described later and the gross anatomic 
appearance of the healing cartilage lesions 
recorded by photography. The general appearances 
of the repair tissue and surrounding tissue of the 
experimental and control joints were evaluated. 
The defect tissue was examined for homogeneity, 
level of repair tissue relative to the surrounding 
cartilage surface, color, and junction with the 
surrounding cartilage. The surrounding tissue was 
examined for adhesions, fibrillation, and color. 
SAMPLE HARVESTING AND PREPARATION 
A section of synovial membrane from the area 
lateral to the cannula penetration site in the joint 
capsule was harvested and fixed in 10°//o buffered 
formalin. A sterile bone saw was used to remove 
a rectangular block of cartilage and bone from 
each femur, encompassing the cartilage lesion and 
extending 1.5 cm beyond the edge of the defect into 
normal cartilage and I cm into the subchondral 
bone. The circular repair defect was divided 
parasagittally into thirds. The repair tissue in the 
axial third was harvested and frozen for biochemi- 
cal analysis. The central third of the sample was 
harvested and fixed in 10% buffered formalin. 
THIN SECTION HIGH DETAIL RADIOGRAPHY 
High detail radiography was performed on the 
3-mm bone slabs, using a low energy X-ray field 
(Faxitron X-ray, Hewlett Packard, McMinnville, 
OR) and high detail radiographic film, to evaluate 
the response of the subchondral trabecular bone to 
the implan t . The samples were then placed under 
vacuum in citrate buffered 22% formic acid for 
demineralization. Radiographic'examination every 
3 days determined when demineralization was com- 
plete. The demineralized samples were placed in 
10% buffered formalin until embedded in paraffin 
for histology. 
HISTOLOGY 
Decalcified specimens were embedded in paraffin 
and 6-#m sections made in a sagittal plane for 
histology and histochemistry. Hematoxylin & 
eosin-stained sections were used for morphologic 
evaluation, and sections stained with safranin O 
(counter stained with fast green), and alcian blue 
(counter stained with nuclear fast red), were used 
for histochemical evaluation. The morphology of 
the cell types in the repair tissue was characterized 
as fibrocytic, fibrochondrocytic or chondrocytic. 
Repair tissue was characterized as fibrous, fibro- 
cartilaginous or hyaline cartilage-like. The inten- 
sity of the matrix staining with the cationic stains 
(safranin 0 and alcian blue) was characterized and 
used as an indicator of proteoglycan production. 
The synovial membrane samples were embedded 
in paraffin, and sectioned at 6 pm prior to staining 
with hematoxylin & eosin. The sections were then 
read blind at × 125 magnification by the same 
observer. Villus proliferation, white blood cell 
infiltration, vascular proliferation, perivascular 
connective tissue thickness, subintimal fibrosis 
and mineralization were evaluated. A score from 1 
(absent) to 5 (severe) was assigned to quantitate 
changes in the villi. 
SYNOVIAL FLUID ANALYSIS 
Red blood cell (RBC) and white blood cell (WBC) 
numbers were determined using a Coulter counter 
(Coulter IV, Hialeah, FL). Synovial fluid protein 
was quantified using a coomassie blue spectro- 
photometric analysis [30]. Absorption was 
measured at 595nm. The concentration of hyal- 
uronan in the synovial fluid was determined using 
an alcian blue precipitation spectrophotometric 
analysis [31], with absorbance measured at a wave- 
length of 620 nm. Cytology of the synovial fluid was 
performed by an experienced clinical pathologist. 
STATISTICS 
Lameness core data from control and grafted 
limbs was compared at each time period using a 
Student's paired t-test. Comparison of the histo- 
logic and synovial fluid data from the chondrocyte 
grafted stifles and the controls at each time period 
was done using the Student's paired t-test, since 
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FIG. 4. Gross appearance of a pair of 240 day specimens with repair tissue from the lateral trochlea. Both t e control 
(left) and grafted (right) have irregular epair tissue in the defect which does not fill either defect completely. The 
junction between the repair tissue and surrounding cartilage is easily discernable in both specimens. 
each animal served as its own control.  Comparison 
of the changes in data over the sampling t ime 
periods was then performed by repeated measures 
analysis of variance. Signif icant interact ions of 
t reatment  (graft or control), or time, were assessed. 
The level of signif icance was P ~< 0.05. 
Resu l ts  
CLINICAL EXAMINATION 
There were no differences in the severity of jo int  
effusion or the degree of lameness between grafted 
and control  joints over the course of the study. At 
terminat ion,  all horses except one were sound at 
a walk and trot. Hind limb flexion for 1.5min 
produced a low-grade lameness in 13 joints of 11 
horses. 
All incisions except one healed by pr imary inten- 
tion; part ial  wound ehiscence occurred in one and 
healed without complication. There were no sig- 
nif icant differences (P > 0.05) in lameness, effusion 
and wound heal ing parameters  between exper- 
imental and control,  and between 4- and 8-month- 
old groups. 
GROSS PATHOLOGIC EXAM 
The general  appearance of the repair  t issue and 
surrounding cart i lage was similar in exper imental  
and control  joints at each time period. The repair  
t issue in most joints was opaque and white, with an 
uneven surface that  rare ly  filled the defect to the 
level of the surrounding tissue (Fig. 4). Both stifle 
joints in one horse had a smooth white repair  
t issue that  completely filled the defect. A clear 
demarcat ion line was evident between the repair  
t issue and the surrounding normal  carti lage. 
F ibr i l lat ion of the cart i lage surrounding the defect 
was not noted in any joint. There were no gross 
lesions on the art icu lar  surface of the patella, or 
evidence of synovial  prol i feration. The synovium 
located at the cannula  entry site had a fibrous scar 
present with contract ion of the surrounding tis- 
sues but no other abnormal i t ies were noted. 
HISTOLOGIC AND HISTOCHEMICAL EXAMINATION 
Synovial  membrane histologic scores are pre- 
sented in Table I. There were no signif icant differ- 
ences in any of the categories evaluated. The 
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synovial membrane intimal layer was one to two 
cell layers thick (Fig. 5). Few white blood cells 
were present in the subintimal layer. Fibroplasia 
and subintimal mineralization were rare in the 
experimental nd control joints. 
Grafted and ungrafted efect repair tissue was 
either fibrous or fibrocartilaginous ti sue (Fig. 6). 
Grafted defects had greater numbers of chondro- 
cytic cells in the base of the defect compared to 
nongrafted controls (Fig. 7). However, fibroblasts 
predominated in the surface layers of both grafted 
and nongrafted defects. Chondrocytes in the 
deeper zones of the grafted defects occurred in 
small groups, and on occasion in columns. There 
were no accumulations of WBCs in the repair 
tissue or the subchondral bone of any of the 
defects. Islands of chondrocytes occurred in the 
lower 20-30~/o f the defects, and these had strong 
uptake of safranin O (Fig. 8). Safranin-stained 
tissue in the grafted defects was more extensive 
than in nongrafted efects. The attachment of 
the experimental repair tissue to the surrounding 
cartilage was frequently better than the attach- 
ment of control repair tissue. There was less cleft- 
ing as evidence of demarcation i the experimental 
defects. The surface of the defects was rough and 
uneven in appearance at high power magnifi- 
cation• Minor cloning of chondrocytes had 
occurred in the surrounding cartilage at the edge 
of the defect• A mild to moderate loss of safranin 
metachromasia was apparent in this cartilage in 
the control and experimental sections. 
SYNOVIAL FLUID ANALYSIS 
Results of synovial fluid analyses are presented 
in Table II, There was no significant difference in 
the median volume of synovial fluid retrieved at 
the time of necropsy from grafted (5.0 ml) vs non- 
grafted joints (4.0 ml). There were no significant 
differences in RBC, WBC, protein or hyaluronan 
values between grafted and nongrafted joints at 
any sampling time. There was a trend towards 
higher protein values in grafted vs nongrafted; 
however, this difference was not significant 
(P > 0.05). RBC values were less than 3500 at days 
120 and 240. Mean WBC values peaked on day 4 
and declined to normal by day 14. On days 120 and 
240 mean WBC values were within normal values 
for both experimental nd control joints. 
Discuss ion  
Deep frozen chondrocytes were successfully 
thawed, embedded and cultured in semi-synthetic 
collagen scaffold vehicles, supporting the results of 
~ +~ 
g 
~ +~ 
+~ 
+l+l+l+l 
Y Y Y 
II 
v 
Y Y Y 
54 Sams and Nixon: Chondrocyte-laden collagen scaffolds 
previous in vitro studies [27]. Arthroscopic implan- 
tation of these collagen-chondrocyte composites 
was performed with minimal associated morbidity. 
Polylactic acid tacks firmly anchored the com- 
posite in the defect, preventing the loss of grafted 
chondrocytes which may have occurred in pre- 
vious studies with other graft vehicles [20]. Clini- 
cal, gross histologic and synovial fluid evaluations 
indicated that the chondrocyte implant and tacks 
were tolerated without significant inflammation. 
Immature chondrocytes were used for transplan- 
tation due to their elevated synthetic activity 
compared to chondrocytes from mature animals 
[32]. However, although immature cells are more 
synthetically active, they are less hardy and do not 
survive the harvesting, freezing and culture pro- 
cess as well as mature cells [19]. Culture studies of 
equine chondrocytes indicate that the optimal age 
of chondrocyte donor is approximately 3~ months, 
where the cells remain synthetically active and 
are more resilient to the harvest and storage 
procedures. 
Culturing in monolayer prior to embedding in 
the collagen scaffold allowed thawed cells with 
marginal viability to be eliminated. Nonviable 
cells fail to attach to the flask base and are 
removed with the exchange of exhausted media. 
The viable cells that survive the freezing, thawing 
and initial culture were the hardiest of the cell 
population and the most synthetically active [22]. 
Pre-implantation high density short-term mono- 
layer culture, without cell passage, improves Chon- 
drocyte function and increases the chance of 
survival in the collagen scaffold and recipient graft 
bed [22]. 
Collagen scaffolds have been used for dental 
procedures, hemostasis, body cavity filling and 
reconstructive surgery [28, 33-35]. Intra-articular 
collagen scaffold reaction has not been described 
in detail [36, 37]. The composite provided a biologi- 
cally tolerated resorbable framework that allowed 
the chondrocytes to persist in a 3-dimensional 
vehicle, facilitating maintenance of the chondro- 
cyte phenotype [20, 22, 38]. Histologic evaluation 
and glycosaminoglycan (GAG) assay of collagen 
scaffold disks laden with chondrocytes and as- 
sessed in vitro over 21 days confirmed chondrocyte 
survival and synthetic activity of the graft cells 
FIG. 5. Synovial membrane photomicrographs from (a) an 8-month grafted and (b) a control joint. The intimal layer 
(arrow) is one to two cells thick in both experimental nd control joints. No cellular infiltrate is seen in the subintimal 
layers of either sample (H & E; × 312). 
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FIo. 6. Photomicrographs of sections of (a) 8-month grafted and (b) control repair tissue and surrounding cartilage. 
Clefting can be seen in the control tissue, and a bonding of the repair tissue to the surrounding cartilage in the grafted 
section. Pericellular glycosaminoglycan basophilic staining can be seen deep within both defects, and a loss of matrix 
is evident in the surrounding cartilage immediately adjacent o the repair tissue in both the grafted and control 
sections (H & E; x 8). 
[27]. Culturing chondrocytes in the scaffold 
allowed the ceils to surround themselves with a 
layer of matrix, masking surface antigens [23, 24]. 
Coating the scaffold with liquid collagen gave 
added protection from the host immune response, 
provided some additional stiffness, and prevented 
loss of cells from the chondrocyte-col lagen com- 
posite. 
The lateral trochlea of the femur was chosen as 
the implantation site in this model because it was 
sufficiently large to allow formation of an exten- 
sive defect. Defects of less than 9-mm diameter in 
horses have been shown to heal better than large 
defects, solely as a function of lesion size [39]. 
Matrix flow likely plays a much greater ole in the 
healing of small defects. To assess the success of 
this graft in a clinically relevant lesion, large 
defects were necessary. Most research on art icular 
resurfacing has been done using either rabbits or 
dogs as a model for man. However, defect size and 
location are limited in laboratory animals, and 
do not represent he clinical or biomechanical 
challenge of large defects. 
A grafting procedure that utilized arthroscopic 
rather than arthrotomy techniques for placement 
was an important goal. In man and animals, 
arthroscopy has made arthrotomy largely obsolete, 
particularly in the complex joints such as the knee 
[29, 40]. Surgical  procedures that are less invasive 
lead t6~I0wer morbidity and less intensive patient 
care. Additionally, the arthroscope allows more 
extensive visualization of the joint compared to 
arthrotomy. Complete visualization of the trochlea 
was possible using standard techniques [29]. A 
modified spade bit made a precise circular defect in 
the carti lage and~penetrated he subchondral bone 
only 1-2 mm. In this model, penetration of the 
subchondral bone and the holes drilled for the 
tacks allowed access to vessels and undifferenti- 
ated mesenchymal cells beneath the subchondral 
58 Sams and Nixon: Chondrocyte-laden collagen scaffolds 
and the primary cell types in both defects were 
fibroblasts. Similarly, histochemical staining was 
evident over a thicker zone in the deeper egions 
of the chondrocyte-grafted r pair tissue. The inter- 
territorial areas had less stain uptake and this 
varied directly with the number of chondrocytes 
per unit area. The chondrocytes in cartilage sur- 
rounding the defects, in both the experimental nd 
control joints, had reduced interterritorial  meta- 
chromasia, suggesting either decreased GAG pro- 
duction or loss of GAG through matrix flow into 
the defect. Chondrocyte cloning was seen in this 
region but no evidence of an effective increase in 
GAG production was evident histochemically, 
which is consistent with findings in the l iterature. 
The lack of apparent influx of white blood cells, 
histiocytes, or multinucleated giant cells in 
the repair tissue, subchondral bone or synovial 
membrane suggests that there was either no, or 
minimal, immune response to the chondrocyte 
graft. 
Conclusion 
Chondrocyte-col lagen composite grafts moder- 
ately improved the gross and histologic quality of 
the repair tissue in full thickness defects at 4 and 
8 months post-operatively. An immune mediated 
rejection reaction was not evident on histologic or 
synovial fluid evaluation. Despite the fact that 
in vitro studies showed chondrocytes were able te 
survive in the collagen disk and produce matrix 
[27], the transplantation procedure resulted in 
poorer cartilage in this large defect model than 
similar chondrocyte grafts in laboratory animals. 
Although the graft resulted in improved cartilage 
healing, the quality of the tissue was not normal. 
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